March 31, 2026 · Form 4 insider transaction
Ridloff Elena bought 7,400 shares of Kymera Therapeutics, Inc. at $14.18 per share, a transaction worth $104.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 11, 2025 adopted by the reporting person.